Emerging research suggests that GLP-1RAs may also be beneficial in treating conditions like obstructive sleep apnea (Malhotra et al., 2024), osteoarthritis (Bliddal et al., 2024), metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis with liver fibrosis (MASH) (Loomba et al., 2024), polycystic ovary syndrome (PCOS) (Szczesnowicz et al., 2023), Alzheimers disease (Liang et al., 2024), Parkinsons disease (Kalinderi et al., 2024), and addiction (Klausen et al., 2022)
Find out what research suggests in our article about supplements for arthritis
KPVs strongest evidence for gut inflammation is oral, where inflamed intestinal cells actively absorb it through the PepT1 transporter (upregulated during inflammation)
Potential Cardiovascular Benefits Although research is ongoing, early data suggests reduced inflammation and improved heart-health markers
Stool Elastase